Exudative Macular Degeneration

Related

• 

  Interim Results of the Phase 1-2 PRISM Trial Evaluating 4D-150 a Dual-Transgene Intravitreal Genetic Medicine for Neovascular (Wet) Age-Related Macular Degeneration

  Christine Kay, MD

  Annual Meeting Talks

  2023

• 

  Primary Analysis Results of the Phase 3 Archway Trial of the Port Delivery System With Ranibizumab (PDS) for Patients With Neovascular AMD

  Peter A. Campochiaro, MD

  Updates from the Field

  2020

• 

  RAP Lesions

  Thomas A. Ciulla, MD, MBA, FASRS

  Retina Image Bank: Images of the Week

  2014